Leukemia Clinical Trials

Showing 5041-5060 of 8,366 trials

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

NCT00726830

RATIONALE: Methadone, morphine, or oxycodone may help relieve pain caused by cancer. It is not yet known whether methadone is more effective than morphine or oxycodone in treating pain in patients with cancer. PURPOSE: This randomized clinical trial is studying methadone to see how well it works compared with morphine or oxycodone in treating pain in patients with cancer.

Brain and Central Nervous System TumorsChronic Myeloproliferative DisordersLeukemia+8 more

M.D. Anderson Cancer Center1 participantsStarted Mar 2009

Spartanburg, South Carolina, United States • Houston, Texas, United States

COMPLETED

LUME BioNIS: a Biomarker Study in Patients With NSCLC

NCT02671422

At present there are no approved predictive tumour- or serum-derived biomarkers guiding usage of anti-angiogenic therapies in patients with adenocarcinoma of NSCLC.The objective of this NIS is to examine whether genetic/genomic markers (alone or combined with clinical covariates) could be used to predict OS in NSCLC patients eligible for treatment with Vargatef®. The investigations in this study are exploratory in nature and considered to be hypothesis generating. The results from these investigations may help to expand our understanding of the disease and the response to Vargatef®.

Carcinoma, Non-Small-Cell Lung

Boehringer Ingelheim260 participantsStarted Mar 2016

Krems, Austria • Vienna, Austria • Brussels, Belgium +68 more locations

Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer

LUME BioNIS: a Biomarker Study in Patients With NSCLC

Related Searches

Evaluation of Apricoxib (Selective Cyclooxygenase 2 Inhibition) in Modulating T Regulatory Cells of Patients With Early Stage Non-small Cell Lung Cancer

Predictive Value of PET CT in the Histologic Lymph Node Status of Patients With Squamous Cell Carcinoma of the Oral N0 Clinical and Radiological Cavity.

Assesment of JL1 Expression in Acute Leukemia

Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by Vaccination

Efficacy and Safety of BCD-100 (Anti-PD-1) in Combination With Platinum-Based Chemotherapy as First Line Treatment in Patients With Advanced Non-Squamous NSCLC

Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy

Development of the Balance Recovery Falls-Efficacy Scale for the Community-dwelling Older Adults

Improving Sexually Transmitted Infection (STI) Results Notification and Partner Services

Vaccination With GM-K562 Cells in Patients With Advanced Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML) After Allogeneic Hematopoetic Stem Cell Transplantation

Safety, Tolerability, Pharmacokinetics and Anti-tumour Activity of ASK120067 in Locally Advanced and Metastatic Non Small Cell Lung Cancer

Safety and Efficacy Study of CD22 CAR-T Cells for Relapsed or Refractory Acute Lymphoblastic Leukemia

A Study of MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Study of Pegilodecakin (LY3500518) With Nivolumab Compared to Nivolumab Alone Second-line Tx in Participants With Metastatic Non-Small Cell Lung Cancer

A Study of TQ-B3139 Capsules in Subjects With MET-Altered Advanced Non-small Cell Lung Cancer

A Prospective Study Comparing Two Radiotherapy Dose/Fraction and Omitting CTVs of the Primary Tumor in Limited SCLC

Evaluation of Presumptive Periodic Treatment (PPT) of Sexually Transmitted Infections (STIs)

Skin Barrier Assessment in Pregnancy and at Birth

Pediatric Intensive Care and COVID-19